Harvard Heart Letter

New guidelines update treatment of atrial fibrillation

New guidelines for treating atrial fibrillation include a recommendation to consider newer oral anticoagulant drugs. Compared with warfarin, they are just as effective for preventing a stroke but are less likely to cause dangerous bleeds in the brain.

To continue reading this article you must be registered.

Get Licensed Content to Harvard Health

If you are interested in licensing content from Harvard Health Publications, please contact us using our online form. Our licensing and business development professionals will help you leverage consumer health content from Harvard Medical School as a clear differentiator in helping achieve your business goals.

Contact Us

Customer Log In